Funded Tech Companies
Nurix Therapeutics
Wondering who invested in Nurix Therapeutics? Sanofi Ventures, Boxer Capital and The Column Group joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Nurix Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1700 Owens St. 205
San Francisco, CA 94158
USA
San Francisco, CA 94158
USA
Phone
Website
Email Address
Company Background Information
Overview
Nurix Therapeutics (Nasdaq: NRIX) is focused on the discovery and development of small molecule inhibitors of ubiquitin ligases to treat a broad range of proliferative and degenerative diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
8/4/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Arthur Sands
Vice President
Jean Chang
Vice President
Cristiana Guiducci
VP - Bus. Development
Pierre Beaurang
VP - Finance
Hans Houte
VP - General Counsel
Christine Ring
VP - R & D
Gwenn Hansen
Company Investors
- Sanofi Ventures
- Boxer Capital
- The Column Group
- Third Rock Ventures
- Wellington Management Company
- Foresite Capital (Michael Rome)
- EcoR1 Capital Management
- Bain Capital Life Sciences
- Redmile Group
- The Column Group (Timothy Kutzkey)
- Third Rock Ventures (Mark Goldsmith)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs